Delays in Diagnosis of Hematological Cancers in Children: An Analysis of Symptom Recognition to Diagnosis Timeline and Contributing Factors at a Tertiary Hospital in Uganda - Takeaways - MDSpire

Delays in Diagnosis of Hematological Cancers in Children: An Analysis of Symptom Recognition to Diagnosis Timeline and Contributing Factors at a Tertiary Hospital in Uganda

  • By

  • Joan Nakabiri

  • Brian Agaba

  • Ronald Naitala

  • Betty Najjuuko

  • Catherine Asiimwe

  • Hellen Alamo

  • Brian Mafabi

  • Marilyn Hockenberry

  • John M. Ssenkusu

  • Victoria Nankabirwa

  • November 12, 2025

  • 0 min

Share

  • 1

    Childhood cancers are the leading cause of death from non-communicable diseases among children, with 400,000 diagnoses globally each year.

  • 2

    In low- and middle-income countries, including Uganda, the survival rate for children with cancer is less than 20%, primarily due to late diagnosis.

  • 3

    Delays in diagnosis of pediatric cancers in Uganda are influenced by financial constraints, caregiver knowledge, misdiagnosis, and lack of diagnostic tools.

  • 4

    The study at Mulago National Referral Hospital aimed to determine the time from symptom recognition to diagnosis and identify contributing factors.

  • 5

    Lymphomas and leukemias account for nearly 60% of childhood cancer cases in Uganda, highlighting the need for improved early detection strategies.

Original Source(s)

Delays in Diagnosis of Hematological Cancers in Children: An Analysis of Symptom Recognition to Diagnosis Timeline and Contributing Factors at a Tertiary Hospital in Uganda

  • by Joan Nakabiri, Brian Agaba, Ronald Naitala, Betty Najjuuko, Catherine Asiimwe, Hellen Alamo, Brian Mafabi, Marilyn Hockenberry, John M. Ssenkusu, Victoria Nankabirwa

  • November 12, 2025

Related Content

Hematopoietic cell transplantation and cell therapy activity landscape survey in the Kingdom of Saudi Arabia; a report from the Saudi Society of Blood and Marrow Transplantation (SSBMT)

Clustering of lymphoid neoplasms by cell of origin, somatic mutation and drug usage profiles: a multi-trait genome-wide association study

An image processing tool for the detection of anthracycline-induced cardiotoxicity by evaluating the myocardial metabolic activity in [18F]FDG PET/CT